This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
10 - 12 June, 2025
Congress CenterBasel Switzerland

David Overton
Senior Research Scientist II - Protein Science Pipeline at Immunocore
Speaker

Profile

David Overton is a research scientist within drug discovery at Immunocore, where he works on the engineering of bispecific molecules for autoimmune and inflammatory diseases. In this role he has contributed to the development of a new class of targeted PD-1 agonist molecule. Prior to joining Immunocore, he completed his BSc in biochemistry at the University of Bath.

Agenda Sessions

  • Development of a B-cell Targeted Immune Suppressive PD-1 Bispecific Agonist - A Novel Approach to Treat Type 1 Diabetes

    10:00